Saltar al contenido
Merck

Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland.

Human & experimental toxicology (2012-11-24)
G Marti, K Fattinger, H Zimmermann, A Exadaktylos
RESUMEN

Ritalin® (methylphenidate) is an amphetamine-like prescription stimulant commonly used in the treatment of attention deficit hyperactivity disorder in children and adults. Recently, the recreational use of Ritalin has increased, particularly among young adults. Well-known symptoms of intoxication include signs of sympathetic nervous stimulation, such as agitation, anxiety, tachycardia, hypertension, headache, tremor, and dizziness. This case report describes oral dyskinesia as a rare presentation of Ritalin intoxication, with the review of pathophysiology and some epidemiological data.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Lorazepam solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
(±)-Lorazepam
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Lorazepam, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad